|
Mr. Wheeler was announced as a Director and the new Chief Executive Officer of Momenta Pharmaceuticals on August 24, 2006. Momenta is a biotechnology company specializing in the detailed characterization and engineering of complex sugars. Prior to joining Momenta, Mr. Wheeler was the President of Chiron BioPharmaceuticals, a division of the Chiron Corporation, until it was acquired by Novartis in 2006. In this position he was responsible for all aspects of the division including commercial, research, development, and manufacturing. Mr. Wheeler is a board member of the CEO Roundtable on Cancer, Inc. and the California Healthcare Institute (CHI). He also currently serves on the IBM Life Science Strategic Advisory Council and the Whitehead Institute for Biomedical Research's Board of Associates. Mr. Wheeler holds a BS and an MS degree in chemical engineering from Cornell University, and an MBA from the Wharton School of the University of Pennsylvania, where he majored in marketing and finance. | 